What is Next-Generation Sequencing?
Next-generation sequencing (NGS) is not the name of a specific breast cancer test. Instead, it is a category of tests that look for all the genomic mutations in a...
Read MoreLines of Therapy: New Drugs May Change MBC Treatment
Which therapy to use for the first, second or third line of treatment for metastatic breast cancer is again under investigation because new therapies have become...
Read MoreWhat Are Lines of Therapy and What You Need to Know
“Lines of therapy” is the term used to describe the order in which different therapies are given to people as their disease progresses. In practice, doctors may...
Read MoreWarmest Wishes for 2021
As our community knows, the COVID-19 pandemic greatly affected all aspects of breast cancer care, including clinical trials. Yet, with your support, we have been...
Read MoreWhen to Use Surgery & Radiation to the Breast
Headlines announcing the phase III clinical trial (ECOG-ACRIN 2108) results stated that radiation and surgery to the breast–also called locoregional therapy...
Read MoreMetastatic Trial Search: New & Improved
Metastatic Trial Search has been re-designed and updated. We’ve provided more personalized matching by adding: New biomarkers: PD-L1, Androgen...
Read MoreBody Image and Metastatic Breast Cancer
Research shows that changes to the body caused by metastatic cancer or treatments for metastatic cancer can affect a person’s body image. Body image is how...
Read MoreGiving the Right Dose of Drugs for MBC: The Patient-Centered Dosing Initiative and Project Optimus
The Patient-Centered Dosing Initiative was started by MBC patient advocates, Anne Loeser and Julia Maués. This movement seeks to educate patients, doctors, and...
Read MoreFDA Approves Keytruda®
On November 13, 2020, the FDA approved pembrolizumab (Keytruda®) in combination with chemotherapy for the treatment of patients with locally recurrent...
Read MoreSEARCH OUR SITE
for past articles or specific information.